Foster City, CA, United States of America

Neupharma, Inc.

Calculating rank
USPTO Granted Patents = 41

% Expired Patents = 4.9


Forward Citations = 227

Loading Chart...
Loading Chart...

3 inventors (with patents filed for the assignee):

goldMedal Xiangping Qian (41 out of 92 patents)

silverMedal Yong-Liang Zhu (29 out of 36 patents)

bronzeMedal Yong-Iiang Zhu (1 out of 1 patent)

4.  Yongliang Zhu (0 patent)


Core Competencies:
Quinazolines
Kinase Inhibitors
Pharmaceutical Compositions
Cancer Treatment
Chemical Entities
B-RAF Kinase
Benzenesulfonamide
Steroids

41 patents:

Company Overview
Neupharma, Inc., based in Foster City, CA, specializes in the development of innovative pharmaceutical solutions targeting cancer treatment. The company focuses on advanced chemical entities, including substituted quinazolines, kinase inhibitors, and benzenesulfonamide derivatives, which are integral to its therapeutic strategies. Neupharma's research encompasses a range of chemical compounds, including quinoxaline and steroid derivatives, aimed at enhancing treatment efficacy and patient outcomes in oncology.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Nov 17 2026

Neupharma, Inc. USPTO Patent Assignee Logo
41 Patents

#12 in Foster City, CA

#1,999 in California

#8,462 in US

#16,770 in the World

Foster City, CA (US)
Foster City, CA, United States of America
Forward Citations = 227

3 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Neupharma, Inc.. Retrieved from https://idiyas.com/company/neupharma

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…